NCT04497779View on ClinicalTrials.gov

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

Active, not recruitingOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

November 7, 2025

Study Completion Date

November 7, 2025

Conditions
Asymptomatic COVID-19 Infection Laboratory-ConfirmedSymptomatic COVID-19 Infection Laboratory-Confirmed
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood and/or nasopharyngeal swabs

OTHER

Diagnostic Laboratory Biomarker Analysis

Correlative studies

OTHER

Electronic Health Record Review

Donors and recipients have their medical records reviewed.

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

California Institute for Regenerative Medicine (CIRM)

OTHER

lead

City of Hope Medical Center

OTHER